RespireRx Pharmaceuticals Inc (RSPI)

[ombowstring]

His reply --

John, Perhaps you were listening to a different presentation than I was giving. The take home message can be summarized with the following comments: We cited numerous reasons why one can assume the stock price would be favorably impacted by the middle of next year. I do think that it will take some positive clinical data to drive the price to any substantially higher level, but with three different clinical trials which should produce data by the middle of 08, it would seem like we have a chance for some positive outcomes. We also have a market research study which will produce more precise quantification of market segments for the treatment of respiratory depression and two new Low impact compounds and one High Impact compound heading toward clinical trial, which should provide us with the strongest position ever achieved by Cortex for the AMPAKINE® technology. Right now our job is to execute and get this all done. The stock price will follow if we do our job well. Roger